Filing Manager
Simcere Zaiming, Inc.
Reporting Manager
Simcere Zaiming, Inc.
Symbol
NXTC
Shares outstanding
2,666,425 shares
Disclosed Ownership
338,636 shares
Ownership
13%
Form type
SCHEDULE 13G
Filing time
19 Aug 2025, 21:46:45 UTC
Date of event
20 Jun 2025

Quoteable Key Fact

"Simcere Zaiming, Inc. disclosed 13% ownership in NEXTCURE, INC. Common Stock, par value $0.001 per share (NXTC) on 20 Jun 2025."

Quick Takeaways

  • Simcere Zaiming, Inc. filed SCHEDULE 13G for NEXTCURE, INC. Common Stock, par value $0.001 per share (NXTC).
  • Disclosed ownership: 13%.
  • Date of event: 20 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Aug 2025, 21:46.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Simcere Zaiming, Inc. 13% 338,636 338,636 0 /s/ Renhong Tang Renhong Tang/Chief Executive Officer
Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. 13% 338,636 338,636 0 /s/ Renhong Tang Renhong Tang/Director and Attorney-in-Fact
Hainan Simcere Zaiming Pharmaceutical Co., Ltd. 13% 338,636 338,636 0 /s/ Renhong Tang Renhong Tang/Chief Executive Officer and Chairman of the Board of Directors
Simcere Pharmaceutical Group Limited 13% 338,636 338,636 0 /s/ Jinsheng Ren Jinsheng Ren / Chief Executive Officer and Chairman of the Board of Directors
Ren Jinsheng 13% 338,636 0 338,636 /s/ Jinsheng Ren Jinsheng Ren
Tang Renhong 13% 338,636 0 338,636 /s/ Renhong Tang Renhong Tang